Home Biotech Investors bail out after Gilead's drug pricing fight
 

Keywords :   


Biotech Investors bail out after Gilead's drug pricing fight

2014-12-24 00:59:28| Biotech - Topix.net

The biotechnology sector is having its worst day since April as investors fear health insurers and companies that manage patient's drug benefits will put new pressure on how much the industry can charge for breakthrough treatments. The selloff, prompted by Express Scripts Holding's announcement Monday that it would block its U.S. patients from getting Gilead Sciences's $1,100-a-pill hepatitis C medicine, sent the Nasdaq Biotechnology Index down 4.6 percent, the biggest one-day drop since April.

Tags: drug fight pricing investors

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
05.11Tropical Storm Rafael Wind Speed Probabilities Number 6
05.11Tropical Storm Rafael Public Advisory Number 6
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 6
05.11Why colouring clothes has a big environmental impact
05.11Atlantic Tropical Weather Outlook
More »